side effects of glp-1 agonists Adverse class drugs. Gastrointestinal issues are Curious about GLP-1 medications? They
Description
doi: 10.3181/00379727-102-25338
Adapted from Jastreboff et al
Paraventricular thalamic control of food intake and reward: role of glucagon-like Peptide-1 receptor signaling
Data regarding these three agents from published head-to-head studies suggest that liraglutide may have the largest A1C lowering capability of the three, followed by exenatide once weekly and then exenatide twice daily [Drucker et al
Ushakumari DS, Sladen RN
And so for patients who've had their blood sugar out of control and now it's getting into control, that can cause a shift in their prescription
